Alien Metals (LON: UFO) reports the latest assay results from joint venture partner West Coast Silver for the Elizabeth Hill silver project in Western Australia demonstrate outstanding grades. There are assay results from six holes outstanding. Alien Metals has a 30% interest. The share price jumped 31.5% to 0.1775p.
Revolution Beauty (LON: REVB) has ended its formal sales process and raised £15m at 3p/share. A retail offer could raise up to £1.5m. Co-founder Tom Allsworth is returning as chief executive, and the other co-founder Adam Minto, who still owns 15.8%, is returning as a consultant. The cash will be used to reduce debt, fund capital investment and pay for restructuring costs. There will be a focus on pricing policy, marketing and efficiency. Tom Allsworth, Adam Minto and largest shareholder Debenhams are acquiring a total of 298.8 million shares in the fundraising. Net debt was £29.7m at the end of July 2025. The credit facility will be reduced from £32m to £28m. The share price rebounded 21.8% to 4.255p.
Aptamer Group (LON: APTA) has released an update on licencing. There are multiple non-exclusive licence opportunities for the first enzyme-modulating Optimer. Initial sales forecasts have been provided by one potential licensee and this could cover 15% of Aptamer’s overheads. A second enzyme-modulating Optimer is at a final development stage. There has been positive feedback concerning Optimer evaluation from a top five pharma company. The share price is 14.3% higher at 0.72p.
Shares in iron deficiency treatment developer Shield Therapeutics (LON: STX) continue to rise following yesterday afternoon’s publication of interim results. Interim revenues were 177% higher at $21.4m. Total US prescriptions were 29% ahead at 84,000 in the fist half. Cash flow could be positive by the end of 2025. The share price increased 7.69% to 7.7p.
Animal treatments developer Animalcare (LON: ANCR) has acquired the VHH NGF programme and related assets that were under a licence agreement with Orthros Medical for €700,000. The programme is assessing the effectiveness of antibodies in the treatment of pain caused by osteoarthritis in horses and dogs. The share price improved 3.17% to 260p.
FALLERS
Profit-taking knocked 34.7% off the Sorted Group (LON: SORT) share price, but, at 31p, it is still 63% higher on the week. Marks & Spencer (LON: MKS) has renewed the cloud-based contract for Sorted’s Ship carrier management software. The renewal lasts until September 2028.
Fire extinguisher products developer Zenova Group (LON: ZED) has raised £262,500 at 0.2p/share and this will fund the growth in the order book. There is strong demand in the UK and internationally. The share price fell 6.52% to 0.215p.
Corporate finance business Marechale Capital (LON: MAC) net assets have reduced from £3.35m to £3.03m due to operating losses and a reduction in the value of investments. Revenues were lower. The share price declined 2.63% to 1.85p.